Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

An announcement from Recursion Pharmaceuticals ( ($RXRX) ) is now available. On October 29, 2025, Recursion Pharmaceuticals announced that Roche ...

Discover Denario, the new open-source AI that automates the entire scientific process, from generating hypotheses to ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I ...

Record set in Florida: a 19-foot-long Burmese python is captured in Big Cypress, revealing new clues about the ecological ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.